Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
Divi's Laboratories Limited
DIVISLABDivi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India. Address: Divi Towers, Hyderabad, India, 500032
Analytics
Zielpreis von Wall Street
417 744.81 INRKGV
94.3456Dividendenrendite
0.51 %Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen DIVISLAB
Dividenden-Analyse DIVISLAB
Dividendenwachstum über 5 Jahre
200 %Kontinuierliches Wachstum
–Ausschüttungsquote 5-Jahres-Durchschnitt
32 %Verlauf der Dividende DIVISLAB
Bewertung der Aktie DIVISLAB
Finanzen DIVISLAB
Ergebnisse | 2019 | Dynamik |